Editorial
doi: 10.1056/NEJM199808273390910.
Erythropoietin for end-stage renal disease
- PMID: 9718384
- DOI: 10.1056/NEJM199808273390910
Item in Clipboard
Editorial
Erythropoietin for end-stage renal disease
N Engl J Med.
.
No abstract available
Comment on
-
Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients.N Engl J Med. 1998 Aug 27;339(9):578-83. doi: 10.1056/NEJM199808273390902. N Engl J Med. 1998. PMID: 9718376 Clinical Trial.
-
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.N Engl J Med. 1998 Aug 27;339(9):584-90. doi: 10.1056/NEJM199808273390903. N Engl J Med. 1998. PMID: 9718377 Clinical Trial.
Similar articles
-
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.N Engl J Med. 1998 Aug 27;339(9):584-90. doi: 10.1056/NEJM199808273390903. N Engl J Med. 1998. PMID: 9718377 Clinical Trial.
-
Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients.N Engl J Med. 1998 Aug 27;339(9):578-83. doi: 10.1056/NEJM199808273390902. N Engl J Med. 1998. PMID: 9718376 Clinical Trial.
-
A comparison between once-weekly and twice- or thrice-weekly subcutaneous injection of epoetin alfa: results from a randomized controlled multicentre study.Nephrol Dial Transplant. 2008 Oct;23(10):3240-6. doi: 10.1093/ndt/gfn255. Epub 2008 May 9. Nephrol Dial Transplant. 2008. PMID: 18469158 Clinical Trial.
-
What is needed to achieve a hemoglobin of 11.0-13.0 g/dl in end-stage renal disease.Blood Purif. 2007;25(1):53-7. doi: 10.1159/000096398. Epub 2006 Dec 14. Blood Purif. 2007. PMID: 17170538 Review.
-
Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.Transplant Proc. 1991 Apr;23(2):1831-2. Transplant Proc. 1991. PMID: 2053169 Review. No abstract available.
Cited by
-
Markers of iron status in chronic kidney disease.Hemodial Int. 2017 Jun;21 Suppl 1(Suppl 1):S21-S27. doi: 10.1111/hdi.12556. Epub 2017 Mar 22. Hemodial Int. 2017. PMID: 28328097 Free PMC article. Review.
-
Interaction between the glucocorticoid and erythropoietin receptors in human erythroid cells.Exp Hematol. 2009 May;37(5):559-72. doi: 10.1016/j.exphem.2009.02.005. Exp Hematol. 2009. PMID: 19375647 Free PMC article.
-
The role of glucocorticoid receptor (GR) polymorphisms in human erythropoiesis.Am J Blood Res. 2014 Dec 15;4(2):53-72. eCollection 2014. Am J Blood Res. 2014. PMID: 25755906 Free PMC article.
-
Erythropoietin: A Personal Alice in Wonderland Trip in the Shadow of the Giants.Biomolecules. 2024 Mar 27;14(4):408. doi: 10.3390/biom14040408. Biomolecules. 2024. PMID: 38672425 Free PMC article. Review.
-
Intravenous iron therapy: how far have we come?Rev Bras Hematol Hemoter. 2011;33(6):461-9. doi: 10.5581/1516-8484.20110123. Rev Bras Hematol Hemoter. 2011. PMID: 23049364 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
